ANI Pharma Q4 Profit Soars - Quick Facts

(RTTNews) - ANI Pharmaceuticals, Inc (ANIP) reported that fourth-quarter net earnings soared to $20.01 million or $1.82 per share from $3.43 million or $0.36 per share in the prior-year quarter, which included $0.01 per share of gain from discontinued operations.

Excluding items, adjusted net income for the quarter was $22.27 million or $1.94 per share.

Net revenues for the quarter doubled to a record $21.04 million from $10.53 million in the same quarter last year.

On average, three analysts polled by Thomson Reuters expected that company to report earnings of $0.58 per share, on revenues of $17.98 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2015, the company expects adjusted earnings in a range of $2.48 to $2.72 per share, on projected net revenues between $80 million and $88 million. Street is currently looking for full-year 2015 earnings of $2.67 per share on annual revenues of $91.63 million.